日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lysophosphatidic acid-induced Arf6-driven macropinocytosis of CD147(+) extracellular vesicles promotes sorafenib resistance of hepatocellular carcinoma

溶血磷脂酸诱导的Arf6驱动的CD147(+)细胞外囊泡巨胞饮作用促进肝细胞癌对索拉非尼的耐药性

Qian, Luomeng; Fu, Zhiguang; Chen, Ping; Guo, Yuan; Li, Yutong; Wang, Yang; Wang, Bo; Zhang, Qing; Guo, Qingjun; Wu, Lidi; Kucharzewska, Paulina; Chen, Zhesheng; Piao, Yongjun; Zhang, Sihe

Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway.

长链非编码RNA STMN1P2通过hnRNPU-EZH2-TARF6-MALT1-caspase-1通路抑制细胞焦亡,从而促进乳腺癌对阿霉素的耐药性。

Jin You-Ping, Xu Bu-Jie, Zhang Xiu-Fen, Wang Xue, Wang Li, Li Lu-Ying, Chen Shu-Yi, Zhu Ping, Zhi Xiu-Ling, Lv Lei, Wang Chao-Fu, Wang Zheng-Lin, Sun Yang-Bai, Zhou Ping

Autism spectrum disorder-associated Sema5A p.Arg676Cys drives Arf6/FE65 signaling and aberrant cell morphogenesis

与自闭症谱系障碍相关的Sema5A p.Arg676Cys突变驱动Arf6/FE65信号通路和异常细胞形态发生

Takahashi, Mikito; Yako, Hideji; Miyamoto, Yuki; Kukimoto-Niino, Mutsuko; Shirouzu, Mikako; Yamauchi, Junji

ARF6 controls VSMC phenotypic switching upon lipid stimulation to promote inflammatory signaling contributing to the progression of atherosclerosis.

ARF6 控制 VSMC 在脂质刺激下的表型转换,促进炎症信号传导,从而促进动脉粥样硬化的进展。

Fiola-Masson Émilie, Campbell Shirley, Laplante Véronique, Lejri Rania, Kanaho Yasunori, Gauchat Jean-François, Servant Marc J, Claing Audrey

Nicotine-free electronic vape fluid stimulates angiogenic processes in vitro through ARF6-mediated oxidative stress.

不含尼古丁的电子烟液通过 ARF6 介导的氧化应激在体外刺激血管生成过程。

Silencing of Rac1 and Arf6 reduces time-dependent and carbachol-induced contractions, proliferation, survival and growth in human bladder smooth muscle cells

抑制Rac1和Arf6可降低人膀胱平滑肌细胞的时间依赖性和卡巴胆碱诱导的收缩、增殖、存活和生长。

Qian, Siwei; Hu, Sheng; Zhu, Wenbin; Tamalunas, Alexander; Stief, Christian G; Hennenberg, Martin

Methuosis key gene ARF6 as a diagnostic, prognostic and immunotherapeutic marker for prostate cancer: based on a comprehensive pan-cancer multi-omics analysis

基于全面的泛癌多组学分析,Methuosis关键基因ARF6可作为前列腺癌的诊断、预后和免疫治疗标志物。

Yongjin Yang,Liangliang Qing,Chengyu You,Qingchao Li,Wenbo Xu,Zhilong Dong

Endothelial Arf6 sustains capillary electrical signaling and cerebral blood flow through PIP(2) regeneration and activation of Kir2.1 channels

内皮细胞Arf6通过PIP(2)再生和Kir2.1通道的激活来维持毛细血管电信号传导和脑血流。

Noterman-Soulinthavong, Maria F; Sancho, María; de la Cruz, Saúl Huerta; Yarboro, Michael; Mandala, Maurizio; Koide, Masayo; Beaufort, Nathalie; Todorov-Völgyi, Katalin; Moreland, Emma; Hill-Eubanks, David; Dichgans, Martin; Nelson, Mark T

Endothelial-Specific Reduction in Arf6 Impairs Insulin-Stimulated Vasodilation and Skeletal Muscle Blood Flow Resulting in Systemic Insulin Resistance in Mice

内皮细胞特异性降低Arf6会损害胰岛素刺激的血管舒张和骨骼肌血流,导致小鼠出现全身性胰岛素抵抗

Islam, Md Torikul; Cai, Jinjin; Allen, Shanena; Moreno, Denisse G; Bloom, Samuel I; Bramwell, R Colton; Mitton, Jonathan; Horn, Andrew G; Zhu, Weiquan; Donato, Anthony J; Holland, William L; Lesniewski, Lisa A

Arf6 as a therapeutic target: Structure, mechanism, and inhibitors

Arf6作为治疗靶点:结构、机制和抑制剂

Sun, Dejuan; Guo, Yuanyuan; Tang, Piyu; Li, Hua; Chen, Lixia